Published in World Neurosurg on April 16, 2012
Literature review of various treatment plans and outcomes for brain metastases from colorectal cancer. World Neurosurg (2011) 0.77
Using the radiobiology of radioresistance and radiosurgery to rethink treatment approaches for the treatment of central nervous system metastases. World Neurosurg (2011) 0.75
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
γ knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg (2012) 2.28
Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A (2006) 1.96
Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery (2009) 1.77
[A 90-year-old woman with acute hemiparesis]. Tidsskr Nor Laegeforen (2006) 1.48
Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg (2011) 1.38
A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J (2008) 1.29
Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res (2010) 1.24
NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin. FASEB J (2002) 1.18
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery (2005) 1.16
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmunol (2013) 1.08
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One (2011) 1.05
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Oncotarget (2013) 0.99
Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord (2010) 0.99
Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol (2005) 0.96
Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis (2011) 0.95
Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg (2015) 0.95
Cancer stem cells in the central nervous system--a critical review. Cancer Res (2010) 0.92
Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol (2007) 0.92
Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer (2011) 0.92
Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects. Int J Cancer (2007) 0.91
Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed (2008) 0.87
Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery (2012) 0.87
Myasthenia gravis in individuals over 40. Ann N Y Acad Sci (2003) 0.86
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med (2014) 0.85
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol (2002) 0.84
Interleukin-10 promoter polymorphisms in myasthenia gravis. J Neuroimmunol (2009) 0.82
Focal myositis--neurogenic phenomenon? Neuromuscul Disord (2011) 0.82
CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunol Immunother (2007) 0.81
Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. J Neurooncol (2006) 0.80
Cerebral atypical teratoid/rhabdoid tumor of infancy: long-term survival after multimodal treatment, also including triple intrathecal chemotherapy and gamma knife radiosurgery--case report. Pediatr Hematol Oncol (2003) 0.80
Gamma knife treatment of growing vestibular schwannoma in Norway: a prospective study. Int J Radiat Oncol Biol Phys (2012) 0.78
Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle Nerve (2006) 0.77
The effect of group music therapy on mood, speech, and singing in individuals with Parkinson's disease--a feasibility study. J Music Ther (2012) 0.77
Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments. Cancer Invest (2013) 0.77
Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model. Biomed Res Int (2013) 0.77
Gamma knife stereotactic radiosurgery of Nelson syndrome. Eur J Endocrinol (2008) 0.76
Gamma-knife radiosurgery in pediatric cerebral and skull base tumors. Med Pediatr Oncol (2003) 0.75
Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle Nerve (2011) 0.75
[Treatment of acoustic neuroma]. Tidsskr Nor Laegeforen (2002) 0.75
Aphasia among young patients with ischemic stroke on long-term follow-up. J Stroke Cerebrovasc Dis (2009) 0.75